Navigation Links
HRh Princess Haya Highlights Need for Medical Research
Date:1/8/2010

ASWAN, Egypt, Jan. 8 /PRNewswire-USNewswire/ -- HRH Princess Haya Al Hussein of Jordan yesterday called for more investment in medical research in a keynote speech at a medical conference hosted by the Aswan Heart Centre.

"The progress that we have seen in the last 25 years in paediatric cardiology could not have happened without adequate funding. Many efforts have been made, but much more needs to be done as we acquire more experience and develop better relationships with international groups to spread the benefits of medical research as widely as possible," She said.

Princess Haya delivered the keynote address at the inaugural meeting of the Centre's Science and Practice Series, the Valvular Heart Disease Update. The meeting, organised by the Magdi Yacoub Foundation, will continue until the 9th of January. Princess Haya serves as Honorary President of the Chain of Hope, a distinguished academic partner of the Aswan Heart Centre.

In recognition of Princess Haya's support, the Centre, upon completion of its new premises in 2011, will name its paediatric unit after Sheikha Al Jalila Bint Mohammed Bin Rashid Al Maktoum, the daughter of HH Sheikh Mohammed and HRH Princess Haya.

"With the Sheikha Al Jalila Paediatric Unit at Aswan Heart Centre, the recently opened Sheikha Al Jalila House for the Walter Sisulu Paediatric Cardiac Centre for Africa (WSPCCA) and the Al Jalila Children's Specialty Hospital, each of these organisations, whether in Egypt, South Africa or the United Arab Emirates, are a part of a triangle of knowledge, capitalizing on the research, education and innovation that stems from within," She said.

Developments in cardiac research were a major focus at the medical conference, which also included remarks by HE Dr. Hatem El Gabaly, Egypt's Minister of Health, General Moustafa El Sayed, Governor of Aswan, Dr. Ali Ramzy, President of the Egyptian Cardiac Society and Sir Magdi Yacoub, Professor of Cardiothoracic Surgery National Heart and Lung Institute, Founder of the Chain of Hope foundation as well as the Aswan Heart Centre.

The conference will host a number of distinguished professors and experts in the field, shedding light on recent medical and technological developments in diagnosis and management as well as advancements in basic and molecular research. Live surgeries by Sir Magdi Yacoub will be performed on the third day of the mission demonstrating a variety of aortic valve surgeries.

HRH Princess Haya's participation in this conference is within the context of Her work to protect the rights of children and underprivileged communities to have access to food, healthcare, education and security. She pays particular attention to the health sector by supporting and initiating health programs and projects locally, regionally and internationally. Through Her interest in paediatric cardiology, Princess Haya has encouraged the creation of other centres of excellence for that specialty in the region.

SOURCE Office of HRH Princess Haya Bint Al Hussein

RELATED LINKS
http://www.princesshaya.net

'/>"/>

SOURCE Office of HRH Princess Haya Bint Al Hussein
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Worlds Largest Exhibit of Princess Dianas Dresses Hosted by Appleton Museum
2. Bon Secours, Sentara to Collaborate on Princess Anne Hospital
3. Scientists discover how to improve immune response to cancer at Princess Margaret Hospital
4. Stanford study highlights cost-effective method of lowering heart disease risks
5. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
6. Other highlights in the September 11 JNCI
7. NEWSWEEK International Editions: Highlights and Exclusives, Oct. 1, 2007 Issue
8. Georgia Pecans Fit!: New Campaign Highlights Health Benefits, Recipes, Web Site
9. Highlights from the October 2007 Journal of the American Dietetic Association
10. Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System
11. NEWSWEEK International Editions: Highlights and Exclusives, OCT. 15, 2007 Issue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 2016 , ... "I had a terrible time trying to get my grandson ... if the nebulizer had a more child-friendly design, then children would be more likely ... patent-pending NEBY to avoid the need to deliver medication via a nebulizer mask. The ...
(Date:12/8/2016)... ... 2016 , ... The West Virginia Medical Institute (WVMI) announced ... name change aligns the entire company with its existing Quality Insights branded projects ... are very proud of the achievements associated with the West Virginia Medical Institute ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying ... opened registration today for its 33rd Annual Issues & Research Conference, March ... The theme of the conference is “Persistent Challenges and New Opportunities: Using Research ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , a New ... Conventional Data Capture Methods for Input to Electronic Health Records: A Comparative Usability ... the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s ...
(Date:12/8/2016)... Virginia (PRWEB) , ... December 08, 2016 , ... ... services company offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care ... operations and general counsel and Eric Hoessel to vice president of sales. ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016   Hudes Laser ... December featuring the multi-wavelength Astanza Trinity laser and ... specializes in laser tattoo removal, IPL hair removal, ... ultrasound therapy. Hudes Laser Aesthetica is setting high ... and promises to deliver effective, long-lasting ...
(Date:12/9/2016)... 2016 Mitsubishi Tanabe Pharma Corporation (Head Office: ... CEO: Dr. Masayuki Mitsuka ) has presented data ... edaravone intravenously in 10-14 day cycles for 48 weeks ... ALS Functional Rating Scale-Revised (ALSFRS-R). The data were presented ... in Dublin, Ireland . ...
(Date:12/9/2016)... , Dec. 9, 2016  Axovant Sciences ... clinical-stage biopharmaceutical company focused on the treatment of ... data from a Phase 2b trial evaluating treatment ... donepezil, compared with donepezil plus placebo in people ... the addition of intepirdine to treatment was associated ...
Breaking Medicine Technology: